On 4 February the Gabinete Técnico Farmacéutico M. Camps and consultancy Azierta organise the webinar "Vigilance and post-marketing of medical devices".
This training, which will be held online for registered users -attendance is free of charge, subject to registration- will provide an overview of regulation and the steps to be taken to carry out PS monitoring.
The market surveillance and monitoring are an essential part of the marketing of medical devices.This is a sector in continuous innovation and of great importance in the European and Spanish market.
The webinar will be moderated by:
- Mercè Camps. CEO and founder of the Technical Pharmaceutical Cabinet MCamps
- Olegario Cuevas. Healthcare Business Manager at Azierta
The webinar presentation will be conducted by:
- Silvia de Andrés. Medical Devices Officer
- Alberto Orós. Technical Consultant
Surveillance and marketing of medical devices:
webinar programme
-
-
- Introduction
- Surveillance system
- Incident management
- Security corrective actions (FSCA) and security notices (FSN)
- Trend reporting
- Post-market surveillance system
- Periodic Security Update Report (PSUR)
- Post Market Monitoring Report (PMSR)
- Post-marketing clinical follow-up
-
Latest articles in our blog
Rapex report 27-5-2016: quiet week for cosmetics
The European Rapid Alert System (RAPEX) withdrew 29 products from the European market on Friday 27 May. Of these, 2 were banned by the Spanish authorities: a toy and a car part. In relation to the cosmetics sector, there have not been any...
AEMPS launches new quarterly newsletter on Cosmetics and Medical Devices
The Spanish Agency for Medicines and Health Products (AEMPS) presented on 13 May its new AEMPS Quarterly Bulletin on medical devices and cosmetics. In this publication, readers will find information on the evolution of the...
New initiative of the pharmacists' associations for cosmetovigilance
On 3 May, Portalfarma, the portal of the General Council of Official Associations of Pharmacists, published the press release “Pharmacies collaborate in the identification of unwanted reactions to cosmetics”. In it, it talks about the initiative of the...